|
2025
|
Invention
|
Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enri... |
|
2022
|
Invention
|
Combination therapy using enantiopure, oxy-substituted, deuterium-enriched 5-(benzyl)-5-deutero-t... |
|
|
Invention
|
Crystalline forms of deuterium-enriched pioglitazone.
Provided herein are crystalline forms of d... |
|
|
Invention
|
Methods of treating subjects having diabetes with chronic kidney disease. The present disclosure ... |
|
2021
|
Invention
|
5-deutero-2,4-thiazolidinedione derivatives and compositions comprising and methods of using the ... |
|
|
Invention
|
Methods of synthesizing enantiopure deuterium-enriched pioglitazone. The invention provides metho... |
|
|
Invention
|
Crystalline forms of deuterium-enriched pioglitazone. Provided herein are crystalline forms of de... |
|
|
Invention
|
Deuterium-enriched pioglitazone. The present application describes deuterium-enriched pioglitazon... |
|
2020
|
Invention
|
5-deutero-thiazolidine-2,4-dione compounds and methods of treating medical disorders using same. ... |
|
2019
|
Invention
|
5-deutero-thiazolidinyldione compounds and methods of treating medical disorders using same.
The... |
|
2018
|
Invention
|
Methods of treating heart failure with preserved ejection fraction. The present invention provide... |
|
2017
|
Invention
|
Methods of treating bacterial infections and fungal infections using enantiopure deuterium-enrich... |
|
2014
|
Invention
|
Deuterium-enriched pioglitazone.
The present application describes deuterium-enriched pioglitazo... |
